Table 4.
Detection of MV RNA in biological fluids/excretions by RT-qPCR at day 11
Treatment group | Detection of viral RNA | Result infectivity assay | ||||
---|---|---|---|---|---|---|
Signal < LODa | Positive signal (+)b | |||||
Animals (N) | Body fluid | Animals (N) | Body fluid | |||
NaCl | Group 1 | – | – | – | – | – |
Group 4 | – | – | – | – | – | |
MV1-F4 | Group 2 | 2 M | Faeces | – | – | Negative |
Group 5 | 1 F | Urine, vaginal secretion | – | – | Negative | |
Group 7 | – | – | – | – | – | |
Rouvax | Group 3 | 1 F | Nasal swab | – | – | Negative |
Group 6 | 1 M | Serum, faeces, PBMCs | 1 M | Throat swab | Negative | |
1 M | Nasal swab, faeces | |||||
1 F | Throat swab, vaginal secretion | |||||
Group 8 | 1 MM | PBMCs | – | – | Negative |
(M)M/F (mature) male/female; N no. of animals with positive signal in sample/no. of tested animals in that group
a<LOD: RNA signal detected but the number of copies was less than the defined LOD of 100 genome equivalent (geq)/reaction (with 95 % chance to detect a positive signal).
b+: positive signal, i.e., signal > defined LOD of the RT-qPCR assay (with 95 % probability)